Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Multiple Myeloma Cells Express IL-17A Creating An Autocrine Loop: An Attractive Therapeutic Target

Rao H. Prabhala, Ph.D., Mariateresa Fulcinitti, PhD, Dheeraj Pelluru, PhD, Harsha K. Prabhala, MS, Naim Rashid, PhD, Adam Sperling, MD, PhD, Puru Nanjappa, MS, Saem Lee, B.A., Andreea Negroiu, MD, Suzan Lazo-Kallanian, BS, Aditya Munshi, MD, Paul G. Richardson, MD, John Daley, PhD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2013) 122 (21): 3113.

https://doi.org/10.1182/blood.V122.21.3113.3113

Published: 2013

Journal Articles

Reprogramming Aberrant B Cell-Subsets to Improve Immune Function in Multiple Myeloma

Rao H. Prabhala, Ph.D., Andreea Negroiu, MD, Saem Lee, B.A., Mariateresa Fulciniti, PhD, Puru Nanjappa, Ms, Harsha K. Prabhala, Adithya Munshi, MD, Irene M. Ghobrial, MD, Paul G. Richardson, MD, Jacob Laubach, MD, John Daley, PhD, Steven P. Treon, M.D., Ph.D., Charles Allam, MD, Kenneth C. Anderson, MD, Nikhil C Munshi, MD

Blood (2012) 120 (21): 3986.

https://doi.org/10.1182/blood.V120.21.3986.3986

Published: 2012

Journal Articles

Once a Week Bortezomib with Dexamethasone Is Effective with Limited Toxicity in Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities,

Nikhil C. Munshi, MD, Saem Lee, B.A., Suman Kambhampati, M.D., Michal Rose, M.D., Abid Mohiuddin, M.D., Yvonne Efebera, M.D., Andrew Han, B.A., Antoun Houranieh, RPh., M.S., Ph.D., Abraham Zimelman, M.D., Mary T. Brophy, M.D., Rao Prabhala, Ph.D., Terrence Grady, DO, PhD, Paulette Mehta, M.D, MPH, Teresa G Hayes, M.D., Sarvari Venkata Yellapragada, MBBS, MD, Caroline Behler, M.D., Catherine Klein, M.D., David Roodman, MD, PhD, Alan K. Lichtenstein, M.D.

Blood (2011) 118 (21): 3964.

https://doi.org/10.1182/blood.V118.21.3964.3964

Published: 2011

Journal Articles

Elevated Homologous Recombination Induces Karyotypic Changes and Predicts Poor Clinical Outcome In Multiple Myeloma

Jagannath Pal, Jeffrey Sawyer, Samir B. Amin, MBBS, Cheng Li, Puru Nanjappa, Saem Lee, B.A., Stephane Minvielle, Hervé Avet-Loiseau, Masood Shammas, Nikhil C. Munshi

Blood (2010) 116 (21): 1924.

https://doi.org/10.1182/blood.V116.21.1924.1924

Published: 2010

Journal Articles

Inhibition of Homologous Recombination Pathway Promotes Telomere Shortening and Cell Survival without Affecting Telomerase Activity In Myeloma

Jagannath Pal, Jason Wong, Puru Nanjappa, Saem Lee, B.A., Masood Shammas, Nikhil C. Munshi, MD

Blood (2010) 116 (21): 786.

https://doi.org/10.1182/blood.V116.21.786.786

Published: 2010

Journal Articles

Interleukin-17 and T H 17 Pathway Supports Waldenstrom's Macroglobulinemia Cell-Growth: Potential Therapeutic Implications

Rao H Prabhala, Ph.D., Dheeraj Pelluru, PhD, Mariateresa Fulciniti, PhD, Puru Nanjappa, MS, Christine Pai, BS, Saem Lee, B.A., Nithya Prabhala, John Daley, PhD, Steven P. Treon, MD, PhD, Nikhil C. Munshi, MD

Blood (2010) 116 (21): 446.

https://doi.org/10.1182/blood.V116.21.446.446

Published: 2010

Journal Articles

Human Monoclonal Antibody Targeting IL-17A (AIN457) Down-Regulates MM Cell-Growth and Survival and Inhibits Osteoclast Development In Vitro and In Vivo: A Potential Novel Therapeutic Application In Myeloma

Rao H Prabhala, PH.D., Mariateresa Fulciniti, PhD, Dheeraj Pelluru, PhD, Puru Nanjappa, MS, Christine Pai, BS, Saem Lee, B.A., Nithya Prabhala, Weihua Song, MD, Constantine S. Mitsiades, MD, PhD, Konstantinos Lefkimmiatis, PhD, Yu-Tzu Tai, PhD, Irene Ghobrial, MD, Paul Richardson, MD, John Daley, Kenneth C. Anderson, MD, Seth Ettenberg, Franco Di Padova, Nikhil C. Munshi, MD

Blood (2010) 116 (21): 456.

https://doi.org/10.1182/blood.V116.21.456.456

Published: 2010

Journal Articles

Interim Results of An Ongoing Clinical Study Suggests Efficacy and Improved Toxicity Profile with Once a Week Bortezomib with Dexamethasone In Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities

Nikhil C. Munshi, M.D., Saem Lee, B.A., Suman Kambhampati, M.D., Abid Mohiuddin, M.D., Michal Rose, M.D., Caroline Behler, M.D., Andrew Han, B.A., Yvonne Efebera, M.D., Antoun Houranieh, RPh., M.S., Ph.D., Mary T. Brophy, M.D., Abraham Zimelman, M.D., Rao H Prabhala, Ph.D., Hussain I. Saba, M.D, Ph.D, Catherine Klein, M.D., Paulette Mehta, M.D, MPH, Teresa Hayes, M.D., David Roodman, M.D, Ph.D, Alan K. Lichtenstein, M.D.

Blood (2010) 116 (21): 3061.

https://doi.org/10.1182/blood.V116.21.3061.3061

Published: 2010

NARROW

Multiple Myeloma Cells Express IL-17A Creating An Autocrine Loop: An Attractive Therapeutic Target

Reprogramming Aberrant B Cell-Subsets to Improve Immune Function in Multiple Myeloma

Once a Week Bortezomib with Dexamethasone Is Effective with Limited Toxicity in Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities,

Elevated Homologous Recombination Induces Karyotypic Changes and Predicts Poor Clinical Outcome In Multiple Myeloma

Inhibition of Homologous Recombination Pathway Promotes Telomere Shortening and Cell Survival without Affecting Telomerase Activity In Myeloma

Interleukin-17 and T H 17 Pathway Supports Waldenstrom's Macroglobulinemia Cell-Growth: Potential Therapeutic Implications

Human Monoclonal Antibody Targeting IL-17A (AIN457) Down-Regulates MM Cell-Growth and Survival and Inhibits Osteoclast Development In Vitro and In Vivo: A Potential Novel Therapeutic Application In Myeloma

Interim Results of An Ongoing Clinical Study Suggests Efficacy and Improved Toxicity Profile with Once a Week Bortezomib with Dexamethasone In Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only